SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Idexx Laboratories Inc/DE – ‘10-Q’ for 3/31/20 – ‘ZIP’

On:  Thursday, 4/30/20, at 5:27pm ET   ·   For:  3/31/20   ·   Accession #:  874716-20-18   ·   File #:  0-19271

Previous ‘10-Q’:  ‘10-Q’ on 10/31/19 for 9/30/19   ·   Next:  ‘10-Q’ on 7/31/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 5/1/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/30/20  Idexx Laboratories Inc/DE         10-Q        3/31/20  101:9.4M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.23M 
 2: EX-10.1     Material Contract                                   HTML     31K 
 3: EX-10.2     Material Contract                                   HTML     35K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     35K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     35K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     30K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     30K 
21: R1          Cover Page                                          HTML     80K 
79: R2          Condensed Consolidated Balance Sheets               HTML    142K 
90: R3          Condensed Consolidated Balance Sheets               HTML     41K 
                (Parenthetical)                                                  
56: R4          Condensed Consolidated Statements of Income         HTML     97K 
20: R5          Condensed Consolidated Statements of Comprehensive  HTML     69K 
                Income                                                           
78: R6          Condensed Consolidated Statements of Comprehensive  HTML     39K 
                Income (Parenthetical)                                           
89: R7          Condensed Consolidated Statements of Stockholders'  HTML     62K 
                Equity (Deficit)                                                 
51: R8          Condensed Consolidated Statements of Stockholders'  HTML     29K 
                Equity (Deficit) (Parenthetical)                                 
22: R9          Condensed Consolidated Statements of Cash Flows     HTML    113K 
15: R10         Basis of Presentation and Principles of             HTML     38K 
                Consolidation                                                    
48: R11         Accounting Policies                                 HTML     34K 
80: R12         Revenue Recognition                                 HTML    118K 
67: R13         Acquisitions                                        HTML     31K 
16: R14         Share-Based Compensation                            HTML     44K 
49: R15         Credit Losses                                       HTML     37K 
81: R16         Inventories                                         HTML     38K 
68: R17         Leases                                              HTML     51K 
17: R18         Other Current and Long-Term Assets                  HTML     55K 
47: R19         Accrued Liabilities                                 HTML     48K 
100: R20         Debt                                                HTML     93K  
64: R21         Repurchases Of Common Stock                         HTML     49K 
35: R22         Income Taxes                                        HTML     31K 
42: R23         Accumulated Other Comprehensive Income              HTML    105K 
101: R24         Earnings Per Share                                  HTML     47K  
65: R25         Commitments, Contingencies and Guarantees           HTML     33K 
36: R26         Segment Reporting                                   HTML    145K 
43: R27         Fair Value Measurements                             HTML    112K 
99: R28         Hedging Instruments                                 HTML    102K 
66: R29         Subsequent Events (Notes)                           HTML     30K 
71: R30         Accounting Policies (Policies)                      HTML     76K 
84: R31         Revenue Recognition (Tables)                        HTML     60K 
46: R32         Share-Based Compensation (Tables)                   HTML     40K 
14: R33         Inventories (Tables)                                HTML     39K 
70: R34         Leases (Tables)                                     HTML     47K 
83: R35         Other Current and Long-Term Assets (Tables)         HTML     57K 
45: R36         Accrued Liabilities (Tables)                        HTML     49K 
13: R37         Debt (Tables)                                       HTML     85K 
69: R38         Repurchases of Common Stock (Tables)                HTML     49K 
85: R39         Accumulated Other Comprehensive Income (Tables)     HTML    106K 
61: R40         Earnings Per Share (Tables)                         HTML     47K 
95: R41         Segment Reporting (Tables)                          HTML    143K 
41: R42         Fair Value Measurements (Tables)                    HTML    101K 
32: R43         Hedging Instruments (Tables)                        HTML     85K 
60: R44         Accounting Policies (Details)                       HTML     44K 
94: R45         Revenue Recognition (General Narrative) (Details)   HTML     32K 
40: R46         Revenue Recognition (Lease Revenue) (Details)       HTML     29K 
31: R47         Revenue Recognition (Extended Warranties and        HTML     43K 
                Post-Contract Support) (Details)                                 
59: R48         Revenue Recognition (Remaining Performance          HTML     73K 
                Obligation) (Details)                                            
96: R49         Revenue Recognition (SaaS Subscriptions) (Details)  HTML     30K 
87: R50         Revenue Recognition (Up-Front Customer Loyalty      HTML     33K 
                Programs) (Details)                                              
72: R51         Revenue Recognition (Volume Commitment Programs)    HTML     38K 
                (Details)                                                        
26: R52         Revenue Recognition (Instrument Rebate Programs)    HTML     33K 
                (Details)                                                        
57: R53         Revenue Recognition (Reagent Rental Programs)       HTML     40K 
                (Details)                                                        
88: R54         Revenue Recognition (Disaggregation of Revenue by   HTML     54K 
                Major Product and Service Categories) (Details)                  
73: R55         Revenue Recognition (Disaggregation of Revenue by   HTML     40K 
                Principal Geographic Area, Based on Customers'                   
                Domiciles) (Details)                                             
27: R56         Revenue Recognition (Costs to Obtain a Contract)    HTML     38K 
                (Details)                                                        
58: R57         Acquisitions Acquisitions (Details)                 HTML     44K 
86: R58         Share-Based Compensation (Narrative) (Details)      HTML     38K 
74: R59         Share-Based Compensation (Assumptions Used)         HTML     39K 
                (Details)                                                        
28: R60         Credit Losses (Details)                             HTML     41K 
38: R61         Inventories (Details)                               HTML     38K 
97: R62         Leases (Maturities of Operating Lease Liabilities)  HTML     56K 
                (Details)                                                        
62: R63         Leases (Narrative) (Details)                        HTML     37K 
29: R64         Leases (Supplemental Cash Flow Information)         HTML     31K 
                (Details)                                                        
39: R65         Other Current and Long-Term Assets (Schedule Of     HTML     45K 
                Other Current Assets) (Details)                                  
98: R66         Other Current and Long-Term Assets (Schedule Of     HTML     47K 
                Other Long-term Assets) (Details)                                
63: R67         Accrued Liabilities (Schedule Of Accrued            HTML     43K 
                Liabilities) (Details)                                           
30: R68         Accrued Liabilities (Schedule Of Other Long-term    HTML     35K 
                Liabilities) (Details)                                           
37: R69         Debt Debt (Schedule of Current Senior Notes         HTML     64K 
                Outstanding) (Details)                                           
53: R70         Debt Debt (Narrative) (Details)                     HTML     57K 
24: R71         Repurchases of Common Stock (Details)               HTML     47K 
76: R72         Income Taxes (Details)                              HTML     30K 
92: R73         Accumulated Other Comprehensive Income (Schedule    HTML     57K 
                Of AOCI) (Details)                                               
52: R74         Accumulated Other Comprehensive Income (Schedule    HTML     42K 
                of Reclassifications out of AOCI) (Details)                      
23: R75         Earnings Per Share (Schedule Of Reconciliation Of   HTML     38K 
                Shares Outstanding For Basic And Diluted Earnings                
                Per Share) (Details)                                             
75: R76         Earnings Per Share (Schedule Of Number Of           HTML     34K 
                Anti-Dilutive Stock Options) (Details)                           
91: R77         Segment Reporting - Allocated Costs (Details)       HTML     73K 
55: R78         Segment Reporting - Summary of Segment Performance  HTML     68K 
                (Details)                                                        
18: R79         Fair Value Measurements (Narrative) (Details)       HTML     33K 
54: R80         Fair Value Measurements (Schedule of Assets and     HTML     73K 
                Liabilities) (Details)                                           
25: R81         Hedging Instruments (Narrative) (Details)           HTML     61K 
77: R82         Hedging Instruments (Derivatives Designated In      HTML     35K 
                Cash Flow Hedging Relationships) (Details)                       
93: R83         Hedging Instruments (Schedule Of Fair Values And    HTML     66K 
                Balance Sheet Classifications Of Derivatives                     
                Designated As Hedging Instruments) (Details)                     
50: R84         Subsequent Events (Details)                         HTML     39K 
34: XML         IDEA XML File -- Filing Summary                      XML    187K 
19: XML         XBRL Instance -- idxx2020q110-q_htm                  XML   2.35M 
33: EXCEL       IDEA Workbook of Financial Reports                  XLSX     98K 
 9: EX-101.CAL  XBRL Calculations -- idxx-20200331_cal               XML    269K 
10: EX-101.DEF  XBRL Definitions -- idxx-20200331_def                XML    631K 
11: EX-101.LAB  XBRL Labels -- idxx-20200331_lab                     XML   1.57M 
12: EX-101.PRE  XBRL Presentations -- idxx-20200331_pre              XML   1.00M 
 8: EX-101.SCH  XBRL Schema -- idxx-20200331                         XSD    172K 
44: JSON        XBRL Instance as JSON Data -- MetaLinks              370±   540K 
82: ZIP         XBRL Zipped Folder -- 0000874716-20-000018-xbrl      Zip    306K 


‘ZIP’   —   XBRL Zipped Folder — 0000874716-20-000018-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:a102ayerssenioradvisor.htm
idxx-20180331x10qg001a06.jpg
idxx-20180331x10qg002a05.jpg
idxx-20180331x10qg003a06.jpg
idxx-20180331x10qg004a07.jpg
idxx-20200331.xsd
idxx-20200331_cal.xml
idxx-20200331_def.xml
idxx-20200331_lab.xml
idxx-20200331_pre.xml
idxx2020q110-q.htm
idxx2020q110-qexhibit311.htm
idxx2020q110-qexhibit312.htm
idxx2020q110-qexhibit321.htm
idxx2020q110-qexhibit322.htm
ortholetterwaiver-conf.htm


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/24  IDEXX Laboratories, Inc.          10-K       12/31/23  140:15M
 2/16/23  IDEXX Laboratories, Inc.          10-K       12/31/22  136:15M
 2/16/22  IDEXX Laboratories, Inc.          10-K       12/31/21  151:18M
 2/12/21  IDEXX Laboratories, Inc.          10-K       12/31/20  131:15M
Top
Filing Submission 0000874716-20-000018   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 6:53:27.1am ET